loadpatents
name:-0.011859893798828
name:-0.004626989364624
name:-0.0046358108520508
Drake; Charles G. Patent Filings

Drake; Charles G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drake; Charles G..The latest application filed is for "treatment of prostate cancer by androgen ablation and il-8 blockade".

Company Profile
3.4.9
  • Drake; Charles G. - New York NY
  • Drake; Charles G. - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Prostate Cancer By Androgen Ablation And Il-8 Blockade
App 20220040252 - Drake; Charles G. ;   et al.
2022-02-10
T Cell Regulation
App 20210230275 - Pardoll; Drew ;   et al.
2021-07-29
Methods of increasing T cell immune response in the treatment of cancer
Grant 10,934,354 - Pardoll , et al. March 2, 2
2021-03-02
Manipulation Of Regulatory T Cell And Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists And Antagonists
App 20190240327 - Yu; Hong ;   et al.
2019-08-08
Compositions and methods for modulating an immune response
Grant 10,329,617 - Drake , et al.
2019-06-25
T Cell Regulation
App 20180251550 - Pardoll; Drew M. ;   et al.
2018-09-06
Immunogenic Fusion Proteins For The Treatment Of Cancer
App 20180085446 - Brockstedt; Dirk G. ;   et al.
2018-03-29
Immunogenic fusion proteins for the treatment of cancer
Grant 9,808,516 - Brockstedt , et al. November 7, 2
2017-11-07
Compositions and methods for modulating an immune response
Grant 9,523,126 - Drake , et al. December 20, 2
2016-12-20
Compositions And Methods For Modulating An Immune Response
App 20160354464 - Drake; Charles G. ;   et al.
2016-12-08
Immunogenic Fusion Proteins For The Treatment Of Cancer
App 20160324945 - Brockstedt; Dirk G. ;   et al.
2016-11-10
Compositions And Methods For Modulating An Immune Response
App 20140335530 - Drake; Charles G. ;   et al.
2014-11-13
Manipulation Of Regulatory T Cell And Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists And Antagonists
App 20140186374 - Yu; Hong ;   et al.
2014-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed